AI Model Rivals Troponin Test in Heart Attack Diagnosis

Researchers develop an Artificial Intelligence model that effectively predicts the need for urgent heart attack treatment, matching high-sensitivity testing accuracy.

An artificial intelligence model trained to detect blocked coronary arteries using electrocardiogram (ECG) readings has been shown to perform on par with high-sensitivity troponin T testing. According to research presented at the American College of Cardiology’s Annual Scientific Session, the AI model was able to identify which patients required urgent treatment for heart attacks with significant accuracy.

Unlike other AI tools focused on high-risk populations, this open-source model was designed for broader application across general emergency department populations. It demonstrated particular efficacy in diagnosing non-ST elevation myocardial infarction (NSTEMI) heart attacks, which typically challenge clinicians due to their subtle ECG changes. The model’s ability to improve prediction speed for urgent coronary revascularization could reduce treatment delays.

The research involved training on data from roughly 145,000 emergency visits and validating it on 35,000 further cases, both internally and across a German center. The model outperformed clinician ECG interpretation and conventional troponin testing, showing potential to complement clinical diagnostics by providing earlier alerts and triggering confirmatory testing. Future studies are being planned to assess its practical application and benefits in a clinical setting.

69

Impact Score

Governance gaps emerge as agentic Artificial Intelligence scales

Agentic Artificial Intelligence is moving from assisted chatbots to autonomous workflows faster than enterprise governance is adapting. The shift raises accountability, security, lifecycle, and cost control challenges that organizations must address in operational code from the start.

Where OpenAI technology could appear in Iran

OpenAI’s Pentagon deal and defense partnerships could place its models in targeting workflows, drone defense systems, and military administration tied to the Iran conflict. The company’s role reflects a broader push to weave generative Artificial Intelligence into US military operations.

Artificial Intelligence tumour testing aims to personalize cancer treatment

A UK-funded cancer testing platform is using living tumour replicas and Artificial Intelligence analysis to identify which drugs are most likely to work before treatment starts. Researchers say the approach could reduce ineffective chemotherapy and improve decisions for patients with aggressive cancers.

Figure advances home robotics with living room cleanup

Figure says its Helix 02 humanoid can now autonomously tidy a living room, marking a step beyond kitchen-focused tasks. The robotics roundup also highlights a DJI vacuum security flaw, new object-finding research, and notable industry moves.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.